...
首页> 外文期刊>Canadian Journal of Biotechnology >Bioinformatics Database Tools in Analysis of Genetics of Neurodevelopmental Disorders
【24h】

Bioinformatics Database Tools in Analysis of Genetics of Neurodevelopmental Disorders

机译:用于神经发育障碍遗传学分析的生物信息学数据库工具

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Bioinformatics tools are recently used in various sectors of biology. Many questions regarding Neurodevelopmental disorder which arises as a major health issue recently can be solved by using various bioinformatics databases. Schizophrenia is such a mental disorder which is now arises as a major threat in young age people because it is mostly seen in case of people during their late adolescence or early adulthood period. Databases like DISGENET, GWAS, PHARMGKB, and DRUGBANK have huge repository of genes associated with schizophrenia. We found a lot of genes are being associated with schizophrenia, but approximately 200 genes are found to be present in any of these databases. After further screening out process 20 genes are found to be highly associated with each other and are also a common genes in many other diseases also. It is also found that they all are serves as a common targeting gene in many antipsychotic drugs. After analysis of various biological properties, molecular function it is found that these 20 genes are mostly involved in biological regulation process and are having receptor activity. They are belonging mainly to receptor protein class. Among these 20 genes CYP2C9, CYP3A4, DRD2, HTR1A, HTR2A are shown to be a main targeting genes of most of the antipsychotic drugs and are associated with more than 40% diseases. The basic findings of the present study enumerated that a suitable combined drug can be design by targeting these genes which can be used for the better treatment of schizophrenia.
机译:生物信息学工具最近被用于生物学的各个领域。可以通过使用各种生物信息学数据库解决有关神经发育障碍的许多问题,这些问题最近已成为主要的健康问题。精神分裂症是一种精神障碍,现在已成为年轻人的主要威胁,因为它主要发生在青少年晚期或成年初期。像DISGENET,GWAS,PHARMGKB和DRUGBANK这样的数据库拥有与精神分裂症相关的巨大基因库。我们发现许多基因与精神分裂症有关,但在这些数据库中的任何一个中都发现了大约200个基因。经过进一步筛选后,发现有20个基因彼此高度相关,并且在许多其他疾病中也是常见基因。还发现它们都是许多抗精神病药中共同的靶向基因。通过分析各种生物学特性和分子功能,我们发现这20个基因主要参与生物调节过程,并具有受体活性。它们主要属于受体蛋白类别。在这20个基因中,CYP2C9,CYP3A4,DRD2,HTR1A和HTR2A被证明是大多数抗精神病药物的主要靶向基因,并且与40%以上的疾病相关。本研究的基本发现列举了可以通过靶向这些基因来设计合适的联合药物,这些基因可用于更好地治疗精神分裂症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号